ISCUCIN mali Strength F Ampoules

Pack size:10 x 1 ml Dosage form:Ampoules

Iscucin Mali Strength F, liquid dilution for injection. Active ingredient: Viscum album (Mali) e planta tota K. Indications: In accordance with anthroposophical understanding of man and nature. These include: In adults: Stimulation of formative and integrative forces for the dissolution and reintegration of independent growth processes, e.g. in malignant tumors, also with accompanying disorders of the blood-forming organs%%% in benign tumors%%% in defined precancerous conditions%%% Recurrence prevention after tumor operations%%% in chronic cross-border diseases (e.g. Crohn's disease%%% chronic joint diseases).

For risks and side effects, read the package insert and ask your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Iscucin Mali Strength F, Liquid Dilution for Injection
Active ingredient: Viscum album (Mali) e planta tota K

Composition:
1 ampoule contains: Viscum album (Mali) e planta tota K Dil. Strength F 1 ml (HAB, Vs. 38).

Indications:
According to the anthroposophical understanding of man and nature. These include: In adults: Stimulation of formative and integrative forces for the dissolution and reintegration of independent growth processes, e.g.

• in malignant tumor diseases, also with accompanying disorders of the blood-forming organs%%%
• in benign tumor diseases%%%
• with defined precancerous conditions%%%
• Recurrence prevention after tumor surgery%%%
• in chronic cross-border diseases (e.g. Crohn's disease, chronic joint diseases).

Contraindications:
Iscucin Mali should not be used in the following cases:

• known allergy to mistletoe preparations.
• acute inflammatory or high fever diseases, treatment should be interrupted until the signs of inflammation subside.
• chronic granulomatous diseases and florid autoimmune diseases and those under immunosuppressive therapy.
• Hyperthyroidism with tachycardia.

Precautions for use and warnings:
Primary brain and spinal cord tumors or intracranial metastases with risk of increased intracranial pressure: In this case, the preparations should only be administered after strict indication and under close clinical supervision.

What should you bear in mind during pregnancy and breastfeeding?
The effects of the drug on pregnancy, the development of the unborn child, childbirth, and the development of the child after birth, especially the development of blood cell formation and the immune system in the unborn child/infant, have not been studied. The potential risk to humans is therefore unknown. Caution is advised when used during pregnancy and breastfeeding. Consult your doctor before using this medicine.

Ability to drive and operate machinery:
There is no experience with regard to impairment of the ability to drive and operate machinery.

Interactions with other medicinal products:
There are no studies on interactions with other immunomodulating substances (e.g. thymus extracts). When using such preparations close to the patient, careful dosing and monitoring of appropriate immune parameters is recommended.

Dosage and method of administration:
The dosage is always individualized according to the doctor's instructions.

Duration of administration:
The treating physician decides on the duration of administration. In principle, there is no limit to the duration of administration. It is determined by the doctor and depends on the respective risk of relapse and the individual condition and findings of the patient. It should be several years, with breaks of increasing length generally being taken.

Mistakes in use:
Caution is expressly emphasized regarding the need to increase the dosage. An excessive increase in the dosage, particularly when skipping a dilution level in the lower strengths (e.g., from strength C to strength E), can lead to allergic-like reactions that require emergency measures.

Side effects:
What side effects can occur when using Iscucin Mali?
Like all medicines, Iscucin Mali can cause side effects, although not everyone will experience them. A slight increase in body temperature and local inflammatory reactions at the subcutaneous injection site almost always occur at the beginning of treatment and are signs of the patient's reaction. Temporary slight swelling of regional lymph nodes is also harmless. In cases of fever above 38°C (possibly with fatigue, chills, general malaise, headache, and brief dizziness) or in cases of larger local reactions exceeding 5 cm in diameter, the next injection should not be given until these symptoms have subsided and in a reduced strength or dose. The fever induced by Iscucin injection should not be suppressed with antipyretic drugs. If fever persists for more than three days, an infectious process or tumor fever should be considered. Excessive local reactions can be avoided by using a lower strength of the preparation or a lower dose. In this case, the use of 0.1–0.5 ml of the used strength using a graduated 1 ml syringe is recommended. Localized or systemic allergic or allergoid reactions may occur (usually in the form of generalized itching, urticaria, or rash, occasionally with Quincke's edema, chills, shortness of breath, and bronchospasticity, occasionally with shock or as erythema multiforme), which require discontinuation of the drug and initiation of medical treatment. Activation of pre-existing inflammation and inflammatory irritation of superficial veins in the injection area are possible. Here, too, a temporary break in therapy is required until the inflammatory reaction subsides. Chronic granulomatous inflammation (erythema nodosum) and autoimmune diseases (dermatomyositis) have been reported during mistletoe therapy. Symptoms of increased intracranial pressure in brain tumors/metastases have also been reported during mistletoe therapy.

Contents:
10 x 1 ml

Pharmaceutical entrepreneur and manufacturer:
WALA Heilmittel GmbH
Dorfstraße 1
73087 Bad Boll/Eckwälden

This package leaflet was last revised in January 2025.

Source: Information from the Wala catalogue
as of: 04/2025

Active ingredient: Viscum album (Mali) e planta tota K. Indications: According to anthroposophical understanding of man and nature. These include: In adults: Stimulation of formative and integrative forces for the dissolution and reintegration of independent growth processes, e.g. in malignant tumors, also with accompanying disorders of the blood-forming organs%%% in benign tumors%%% in defined precancerous conditions%%% Recurrence prevention after tumor surgery%%% in chronic cross-border diseases (e.g. Crohn's disease%%% chronic joint diseases).